NSUN2 and acute myeloid leukemia: In addition, by targeting the m5C modification mediated by NSUN2, the NSUN2 inhibitor MY-1B and the FSP1 inhibitor iFSP1 were able to significantly inhibit the survival of acute myeloid leukemia (AML) cells (Ye et al., 2025).